Skip to main content
logo
Bioextrax AB (publ) (STO:BIOEX)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.340
-0.040 (-1.68%)
Sep 3, 2026, 3:46 PM CET

Bioextrax AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.021.241.013.012.21.03
Revenue Growth
-19.69%22.55%-66.38%36.81%113.61%363.98%
Gross Profit
-0.03-0.02-0.421.670.85-0
Operating Income
-18.68-17.84-17.54-21.6-18.67-10.53
Net Income
-18.57-17.71-17.34-21.51-18.67-10.53
Earnings Per Share
-0.43-0.45-0.52-0.81-1.10-0.79
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
7.393.9317.2713.427.538.98
Net Cash Growth
-31.53%-77.23%28.87%-51.33%206.69%337.54%
Net Cash Per Share
0.170.100.520.511.630.67
Cash & Investments
7.393.9317.2713.427.538.98

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-15.66-26.05-18.78-23.31-17.6-8.48
Capital Expenditures
-0.32-0.15-0.22-1.1-6.78-0.98
Free Cash Flow
-15.98-26.2-18.99-24.41-24.38-9.45
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-3.32%-1.53%-41.44%55.50%38.81%-0.39%
Operating Margin
-1824.32%-1439.79%-1734.82%-718.29%-849.27%-1023.23%
Pretax Margin
-1813.48%-1428.97%-1714.94%-715.23%-849.27%-1023.52%
Profit Margin
-1813.48%-1428.97%-1714.94%-715.23%-849.27%-1023.52%
FCF Margin
-1560.74%-2114.45%-1878.63%-811.77%-1109.19%-918.56%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
110.6490.46126.2529.5139.85911.58